{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:08:21Z","timestamp":1782439701732,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpba.2025.117048","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:40:44Z","timestamp":1751431244000},"page":"117048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparability of different analytical workflows for steroid esters detection in doping control field"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-930X","authenticated-orcid":false,"given":"Monica","family":"Mazzarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Gansbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00f0alhei\u00f0ur D\u00f3ra","family":"Albertsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-4922","authenticated-orcid":false,"given":"Peter","family":"Van Eenoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117048_bib1","unstructured":"World Anti-Doping Agency. Anti-doping testing figures. 2022. \u3008https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2022_testing_figures_report.pdf\u3009. Accessed 14thFebruary 2025."},{"issue":"10","key":"10.1016\/j.jpba.2025.117048_bib2","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.3390\/molecules191016489","article-title":"Modern prodrug design for targeted oral drug delivery","volume":"19","author":"Dahan","year":"2014","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jpba.2025.117048_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ncpuro0650","article-title":"Drug insight: testosterone preparations","volume":"3","author":"Srinivas-Shankar","year":"2006","journal-title":"Nat. Clin. Pr. Urol."},{"key":"10.1016\/j.jpba.2025.117048_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF03346484","article-title":"Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes","volume":"32","author":"Di Luigi","year":"2009","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jpba.2025.117048_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpba.2014.03.013","article-title":"Use of dried blood spots in doping control analysis of anabolic steroid esters","volume":"96","author":"Tretzel","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11-12","key":"10.1016\/j.jpba.2025.117048_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/dta.3030","article-title":"Stability and detectability of testosterone esters in dried blood spots after intramuscular injections","volume":"14","author":"Solheim","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2025.117048_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123535","article-title":"Detection of 20 endogenous anabolic steroid esters with Girard\u2019s Reagent P derivatization in dried blood spots using UPLC-Q-Orbitrap-MS","volume":"1213","author":"Yuan","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.117048_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/dta.3681","article-title":"Simultaneous detection of testosterone, nandrolone, and boldenone esters in dried blood spots for doping control in sports by liquid chromatography\u2013tandem mass spectrometry","volume":"17","author":"Miyamoto","year":"2024","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2025.117048_bib9","unstructured":"World Anti-Doping Agency. Dried blood spots (DBS) for doping control. WADA Technical Document\u2014TD2023DBS. 2023. Accessed 14thFebruary 2025."},{"key":"10.1016\/j.jpba.2025.117048_bib10","unstructured":"International Standard for Testing and Investigations (ISTI) | World Anti-Doping Agency. \u3008https:\/\/www.wadaama.org\/en\/resources\/laboratories\/international-standard-for-laboratories-isl\u3009. Accessed 14thFebruary 2025."},{"key":"10.1016\/j.jpba.2025.117048_bib11","article-title":"New trends in bioanalysis sampling and pretreatment: how modern microsampling is revolutionising the Field","volume":"13","author":"Protti","year":"2025","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jpba.2025.117048_bib12","doi-asserted-by":"crossref","first-page":"31845","DOI":"10.1021\/acsomega.2c01417","article-title":"UHPLC\u2212HRMS method for the simultaneous screening of 235 drugs in capillary blood for doping control purpose: comparative evaluation of volumetric and non-volumetric dried blood spotting devices","volume":"7","author":"Mazzarino","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2025.117048_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116007","article-title":"Liquid vs dried blood matrices: application to longitudinal monitoring of androstenedione, testosterone, and IGF-1 by LC\u2013MS-based techniques","volume":"242","author":"Mazzarino","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117048_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00216-024-05697-9","article-title":"LC-HRMS screening procedure for the detection of 11 diferent classes of prohibited substances in dried urine spots for doping control purposes","volume":"417","author":"Mazzarino","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.117048_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115274","article-title":"Capillary blood as a complementary matrix for doping control purposes. Application to the definition of the individual longitudinal profile of IGF-1","volume":"227","author":"Stacchini","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117048_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpba.2011.11.015","article-title":"Investigation of dried blood spot card-induced interferences in liquid chromatography\/mass spectrometry","volume":"61","author":"Chen","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2025.117048_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/dta.3226","article-title":"Automated online dried blood spot sample preparation and detection of anabolic steroid esters for sports drug Testing","volume":"14","author":"Jing","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"8","key":"10.1016\/j.jpba.2025.117048_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5633","article-title":"Dried blood spots for doping controls-development of a comprehensive initial testing procedure with fully automated sample preparation","volume":"37","author":"Garzinsky","year":"2023","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2025.117048_bib19","unstructured":"ISO - ISO\/IEC 17025:2017 - General requirements for the competence of testing and calibration laboratories.\u3008https:\/\/www.iso.org\/\u3009 standard\/66912.html. Accessed 14thFebruary 2025."},{"key":"10.1016\/j.jpba.2025.117048_bib20","unstructured":"World Anti-Doping Agency. WADA Technical Document TD2023IDCR.\u3008http:\/\/www.wada\u3009ama.org. Accessed 14thFebruary 2025."},{"key":"10.1016\/j.jpba.2025.117048_bib21","unstructured":"International Standard for Laboratories (ISL) | World Anti-Doping Agency.\u3008https:\/\/www.wada\u3009ama.org\/en\/resources\/laboratories\/international-standard-for-laboratories-isl. Accessed 14th February 2025 ."},{"key":"10.1016\/j.jpba.2025.117048_bib22","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117048_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00216-010-4319-y","article-title":"Accelerated sample treatment for screening of banned doping substances by GC\u2013MS: ultrasonication versus microwave energy","volume":"399","author":"Galesio","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.117048_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/dta.1914","article-title":"Detection of testosterone esters in blood","volume":"7","author":"Forsdahl","year":"2015","journal-title":"Drug Test. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:32:26Z","timestamp":1755084746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"alternative-id":["S0731708525003899"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117048","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparability of different analytical workflows for steroid esters detection in doping control field","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117048"}}